Monoclonal Antibody Prevents Malaria Infection in African Adults
October 31, 2022 -- One dose of an antibody drug safely protected healthy, non-pregnant adults from malaria infection during an intense six-month malaria season in Mali, Africa, a National Institutes of Health clinical trial has... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 31, 2022 Category: Pharmaceuticals Source Type: clinical trials
Gametocytocidal and Transmission-blocking Efficacy of ASAQ and ALAQ With or Without PQ in Mali
Condition: Malaria,Falciparum Interventions: Drug: Artesunate-amodiaquine combination; Drug: Primaquine Phosphate; Drug: Artemether-lumefantrine; Drug: Amodiaquine Sponsor: London School of Hygiene and Tropical Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2022 Category: Research Source Type: clinical trials
